Founder Shalev Hulio to Become Vice Chairman of the Board and the Global President. Isaac (Itzik)…
Categoría: Business Wire
Category Added in a WPeMatico Campaign
New Research for KEYTRUDA® (pembrolizumab) at Society for Melanoma Research (SMR) 2021 Congress Reinforces Merck’s Commitment to Patients With Melanoma Across Stages of Disease
KEYTRUDA Continued To Improve Recurrence-Free Survival (RFS) Compared to Placebo as Adjuvant Therapy for Patients With…
Moderna Provides Update on Timing of U.S. Emergency Use Authorization of its COVID-19 Vaccine for Adolescents
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines,…
Kessler Topaz Meltzer & Check, LLP – Important Deadline Reminder for D-MARKET Elektronik Hizmetler Ve Ticaret Anonim Sirketi a/k/a D-MARKET Electronic Services & Trading d/b/a Hepsiburada Investors
RADNOR, PA.–(BUSINESS WIRE)–$HEPS–The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a…
Cinemark Delivers Best COVID-Era Box Office Performance in Month of October
October box office performance underscores the ongoing demand for strong consumer-appeal film content shown in the…
Hisense Australia Launch New Air Conditioners
QINGDAO, China–(BUSINESS WIRE)–#HiNews–In October, Hisense Australia launched 4 new air conditioners. The range includes Hisense’s Hi-Nano…
Vertiv Group Corporation Announces Pricing of Private Offering of $850 Million of Senior Secured Notes due 2028
COLUMBUS, Ohio–(BUSINESS WIRE)–Vertiv Holdings Co (“Vertiv”) (NYSE: VRT), a global provider of critical digital infrastructure and…
Dicerna Announces Poster Presentations at American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® 2021 in November
LEXINGTON, Mass.–(BUSINESS WIRE)–Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA), a leading developer of investigational ribonucleic acid interference (RNAi)…
Moderna Announces FDA Advisory Committee Unanimously Votes in Support of Emergency Use for a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
Positive unanimous vote for mRNA-1273 booster at the 50 µg dose level for individuals aged 65…
Arcosa, Inc. Announces Timing of Third Quarter 2021 Earnings Release and Conference Call
DALLAS–(BUSINESS WIRE)–Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions,…